Reader sentiment, not investment advice. One vote per visitor; click again to change it.
Shares of Veeva Systems are down 0.52% at $283.98. The company is worth $45.98B, number 329 out of 800 on our list.
Over a full year the shares have ranged across $148.05 to $310.50, which puts the current price roughly 84% of the way up that band.
Revenue for the quarter ended Jul 2026 was $927.96M, up 17.6% from a year earlier, with $273.43M of net profit (a 29.3% margin).
Buyers are paying 46.6 times trailing earnings, 24% below its five-year average of 61.5. The median for its industry group is 32.5.
22 analysts follow the stock and the average call is "buy". The mean target, $294.60, sits 3.7% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 3 factors below, ranked against the 800 U.S. stocks BeStock covers.
Cheaper than usual on its own 5-year P/E history scores higher.
Trading closer to its 52-week high than most peers scores higher.
22 analysts, consensus Buy.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
VEEV is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2020-07-06, the strategy has returned 1524.8% (321.7% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $294.60, 3.7% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $287.00, so shares trade 1.1% below that estimate. On earnings multiple, it sits in the 16th percentile of its own five-year valuation range (cheaper than usual).
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Quote as of Oct 1, 2026 11:50 am ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 800 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
Set against the peer table: at 46.6x earnings, VEEV looks expensive against the market, and trades 43% above the 32.5x median among AI medical concept stocks names. The two comparisons do not always agree.
$283.98 is the latest print for VEEV, a move of -0.52% against yesterday's close of $285.45. Today's low and high so far: $283.46 and $291.00.
Equity value comes to $45.98B at the current price. By that measure it is number 329 of the 800 names in our coverage.
Buyers pay 46.6 times the last twelve months of profit (EPS $5.44). Averaged over five years the multiple has been 61.5, and today's level ranks in the 16th percentile of its own history.
The year's floor is $148.05 and the ceiling $310.50. Shares are 8.5% away from that ceiling.
Our data shows no dividend paid by Veeva Systems over the trailing twelve months.
Of 22 analysts, 73% say buy, 23% hold and 5% sell. Price targets average $294.60, with the most cautious at $180.00 and the most optimistic at $340.00.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on VEEV.